Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
April 2014—Horizon Discovery entered into a collaboration agreement with Desktop Genetics for development of a CRISPR design platform. Horizon will use the platform to identify the best guide-RNAs in the human genome for each gene editing task, as part of its GENESIS suite of gene editing technologies.
April 2014—Nuclea signed development deals with AccuGenomics and Nuvera Biosciences that will include validating two new assays in the treatment of chronic myeloid leukemia and breast cancer.
April 2014—EntroGen expanded its line of colorectal cancer screening products to include the EntroGen K-Ras and N-Ras Mutation Analysis kits. The kits are updated to include coverage for exon 2, 3, and 4 mutations in both genes. The company obtained a CE IVD mark for these products.
April 2014—Horizon Discovery signed a worldwide distribution agreement with Haplogen in which customers can access, directly from Horizon, Haplogen’s Haploid Gene Trap Mutant Collection of isogenic human cell lines deficient for the expression of single genes. This is the first time Horizon will distribute another company’s products.
April 2014—Eppendorf North America added five models to its epMotion range of automated pipetting systems. The epMotion 5075 system uses Eppendorf’s epBlue software and an intuitive software assistant concept that can be easily programmed and requires only initial training for new users.
April 2014—Qiagen announced the launch plans of products designed to reduce the challenges of bottlenecks in next-generation sequencing: sample preparation and bioinformatics. The products add to Qiagen’s portfolio of solutions designed to run with any NGS platform.
April 2014—Dako and Amgen will develop a molecular diagnostic test using Dako’s IQFISH hybridization buffer.
April 2014—SeraCare Life Sciences is offering a nine-member panel made from serial dilutions of a cultured virus with established reactivity for CMV DNA called the CMV DNA AccuSpan Linearity Panel.
April 2014—Siemens Healthcare Diagnostics’ CentraLink Data Management System achieved the highest rating for overall user satisfaction, according to the Middleware Market Monitor, a report published by Information Dynamics. The report reviews the current use of middleware solutions in the main hospital clinical laboratory and tracks changes in product usage or applications.
April 2014—Vital Diagnostics launched the Eon 300 benchtop scalable chemistry analyzer for small to midsize physician office labs, satellite labs, and small hospital labs.
